ViiV IPO Plans Ditched By GSK; New Plan Is To Retain Value
This article was originally published in The Pink Sheet Daily
Executive Summary
The British health care company has decided not to spin out a minority stake in its fast-growing HIV joint venture, in part because of feedback from investors against the idea.